Skip to content
stockresearch.app
ELV/History

Elevance Health (ELV) valuation history

Historically high

As of

ELV's EV/EBITDA of 12.9x is higher than 98% of its available weekly readings from the last five years.

EV/EBITDA weekly history5.3×8.5×11.8×15×Shading: 5-year middle halfMedian 10.5×12.9×202120232025
Share EV/EBITDA history
Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/EBITDA at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

ELV year-end valuation history
Reading dateEV/EBITDA5-year rank
8.1×13%
7.6×6%
9.5×26%
11.5×46%
12.9×83%
9.7×49%
11.8×75%
11.5×79%
10.7×98%
6.7×70%

Loading related research…

About this history

What is ELV's current EV/EBITDA?
ELV's EV/EBITDA of 12.9x is higher than 98% of its available weekly readings from the last five years.
What is ELV's five-year median EV/EBITDA?
The median, or middle weekly reading, is 10.5× over the last five years. Available history contains 860 weekly observations from May 3, 2010 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Source: SEC company filings and weekly market prices. Multiples use the previous twelve months of financial results. Updated .

Read the valuation methodology